EXHIBIT 3
---------
FOR IMMEDIATE RELEASE
Contact:
Bruce Broussard Alvis R. Swinney
832-601-6103 832-601-6174
bruce.broussard@usoncology.com alvis.swinney@usoncology.com
------------------------------ ----------------------------
US Oncology to Present at Raymond James & Associates Healthcare Conference
---------------------------------------------------------------------------
Company to Broadcast Presentation Over the Internet
HOUSTON, September 27, 2001 - US Oncology, Inc. (Nasdaq: USON), will participate
in the Raymond James & Associates Healthcare Conference held October 1 and 2,
2001 in Nashville, Tenn. Dale Ross, chief executive officer and Bruce Broussard,
chief financial officer, will discuss US Oncology's recent business developments
and market opportunities.
In conjunction with this appearance, US Oncology will make its live conference
presentation on the Internet at 8:40AM CDT, Tuesday, October 2, 2001. Those
interested should register at the following web address:
http://customer.nvglb.com/raymondjames/health/.
----------------------------------------------
Participants should go to this site at least 15 minutes before this event to
register and download and install any necessary software, Microsoft Windows
Media Player or RealPlayer. For those unable to view the webcast, a replay will
be available for 90 days by accessing the address above. There is no charge to
access the event.
US Oncology is the world's largest health care network dedicated exclusively to
cancer treatment and research. Together, US Oncology affiliated practices and
cancer centers provide comprehensive outpatient care for approximately 15
percent of the nation's newly diagnosed cancer patients - serving more cancer
patients than any other single organization. US Oncology's network includes more
than 8,900 dedicated physicians, clinicians, nurses and administrators in nearly
500 sites of service, including 75 community-based integrated cancer centers in
27 states.
This press release contains forward-looking statements, including statements
that include the words "believes," "expects," "anticipates," "intends,"
"projects," or similar expressions and statements regarding our prospects. All
statements other than statements of historical fact included in this press
release are forward-looking statements. Although the Company believes that the
expectations reflected in such statements are reasonable, it can give no
assurance that such expectations will prove to have been correct. Matters that
could further impact future results and financial condition include conversion
of net revenue model agreements to earnings model agreements, reimbursement for
healthcare services, particularly reimbursement for chemotherapy agents,
government regulation and enforcement, increases in the cost of providing cancer
treatment services and the operations of the Company's affiliated physician
groups. Please refer to the Company's filings with the Securities and Exchange
Commission, including its Annual Report on Form 10-K for 2000 for factors that
could cause actual results to differ materially from the Company's expectations.
####